Role of alcohol in the progression of liver disease caused by hepatitis C virus infection

被引:216
作者
Ostapowicz, G
Watson, KJR
Locarnini, SA
Desmond, PV
机构
[1] St Vincents Hosp, Dept Gastroenterol, Fitzroy, Vic 3065, Australia
[2] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia
关键词
D O I
10.1002/hep.510270637
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In patients with chronic hepatitis C, alcohol consumption has been proposed as a risk factor for the progression of liver disease; however, evidence for this remains conflicting. Two hundred thirty-four anti-hepatitis C virus (HCV)-positive patients who had a liver biopsy performed within the past 24 months were studied. Demographic data and information on risk factors were recorded, A detailed lifetime alcohol consumption history was obtained. Viral studies included HCV viral titer and HCV genotype, Mean age (+/- SEM) of the group was 40.8 +/- 0.7 years. One hundred sixty-six (71%) were male. A risk factor for HCV infection was found in 195 patients (86%). Genotype distribution was: Ib: 22%; la: 15%; 1(nonsubtypable): 15%; 3a: 34%; and 2: 7%. Fifty (21%) patients had cirrhosis, Patients with cirrhosis were older (51.6 +/- 1.8 years) than those with chronic hepatitis (37.6 +/- 0.6 years; P = .0001), were infected at an older age (25.9 +/- 2.0 vs. 20.9 +/- 0.6 years; P = .001), and had a longer duration of infection (20.5 +/- 1.3 vs. 16.2 +/- 0.5 years; P = .0008). Patients with cirrhosis had a greater total lifetime alcohol consumption (288,765 +/- 58,115; g) than those with chronic hepatitis (189,941 +/- 15,453 g; P = .018). Cirrhotic patients also had greater total alcohol consumption during the period of infection with HCV (240,962 +/- 63,756 g vs. 146,510 +/- 12,862 g; P = .02), On multivariate analysis, subject age and total alcohol consumption were independently associated with the presence of cirrhosis, Total lifetime alcohol consumption is a risk factor for the progression of liver disease caused by HCV.
引用
收藏
页码:1730 / 1735
页数:6
相关论文
共 36 条
[11]   IRON STORAGE, LIPID-PEROXIDATION AND GLUTATHIONE TURNOVER IN CHRONIC ANTI-HCV POSITIVE HEPATITIS [J].
FARINATI, F ;
CARDIN, R ;
DEMARIA, N ;
DELLALIBERA, G ;
MARAFIN, C ;
LECIS, E ;
BURRA, P ;
FLOREANI, A ;
CECCHETTO, A ;
NACCARATO, R .
JOURNAL OF HEPATOLOGY, 1995, 22 (04) :449-456
[12]   QUANTITATION OF HEPATITIS-C VIRUS-RNA IN SERUM OF ASYMPTOMATIC BLOOD-DONORS AND PATIENTS WITH TYPE-C CHRONIC LIVER-DISEASE [J].
HAGIWARA, H ;
HAYASHI, N ;
MITA, E ;
NAITO, M ;
KASAHARA, A ;
FUSAMOTO, H ;
KAMADA, T .
HEPATOLOGY, 1993, 17 (04) :545-550
[13]   Iron overload in patients with chronic hepatitis C: A clinicopathologic study [J].
Haque, S ;
Chandra, B ;
Gerber, MA ;
Lok, ASF .
HUMAN PATHOLOGY, 1996, 27 (12) :1277-1281
[14]   Serum HCV RNA levels assessed by quantitative NASBA(R): Stability of viral load over time, and lack of correlation with liver disease [J].
Hollingsworth, RC ;
Sillekens, P ;
vanDeursen, P ;
Neal, KR ;
Irving, WL .
JOURNAL OF HEPATOLOGY, 1996, 25 (03) :301-306
[15]  
Holtzmuller K, 1996, HEPATOLOGY, V24, P1009
[16]  
HONDA M, 1994, HEPATOLOGY, V20, P1144, DOI 10.1002/hep.1840200507
[17]  
IZOPET J, 1994, HEPATOLOGY, V20, pA241
[18]   QUANTIFICATION OF HEPATITIS-C VIRUS BY COMPETITIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION - INCREASE OF THE VIRUS IN ADVANCED LIVER-DISEASE [J].
KATO, N ;
YOKOSUKA, O ;
HOSODA, K ;
ITO, Y ;
OHTO, M ;
OMATA, M .
HEPATOLOGY, 1993, 18 (01) :16-20
[19]   FORMULATION AND APPLICATION OF A NUMERICAL SCORING SYSTEM FOR ASSESSING HISTOLOGICAL ACTIVITY IN ASYMPTOMATIC CHRONIC ACTIVE HEPATITIS [J].
KNODELL, RG ;
ISHAK, KG ;
BLACK, WC ;
CHEN, TS ;
CRAIG, R ;
KAPLOWITZ, N ;
KIERNAN, TW ;
WOLLMAN, J .
HEPATOLOGY, 1981, 1 (05) :431-435
[20]   NON-A, NON-B POSTTRANSFUSION HEPATITIS - LOOKING BACK IN THE 2ND DECADE [J].
KORETZ, RL ;
ABBEY, H ;
COLEMAN, E ;
GITNICK, G .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (02) :110-115